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Previous studies have shown that CFS patients have an
increased incidence of lympho-proliferative malignancy
compared to the normal population [1]. While the inci-
dence rate of non-Hodgkin’s lymphoma in the United
States is 0.02%, nearly 5% of the CFS patients developed
the disease. Additionally, development of cancer coin-
cides with an outgrowth of gamma delta T cells with
specific clonal T-cell receptor gamma rearrangements.
We hypothesized that infection with XMRV and/or
other viruses can trigger a dysregulated immune
response which favors the development of B-cell
lymphoma.
In a study of 300 CFS patients, 13 developed lympho-
proliferative disorders. Of those tested, 11/11 were posi-
tive for XMRV and 9/9 positive for clonal TCR gamma
rearrangements. Spontaneous development of four B
cells lines occurred during culture of cells from CFS
patients. Three developed from B cells isolated from the
peripheral blood (two of whom had B cell lymphoma)
and one from a bone marrow biopsy. For all four lines,
the B cells have a mature CD20+, CD23+ phenotype
and produce infectious XMRV at a titer of >106 infec-
tious units/ml. Virus production occurred despite exten-
sive hypermutation of the proviruses in these cells by
APOBEC3G.. Therefore XMRV infection may accelerate
the development of B cell malignancies by either indir-
ect chronic stimulation of the immune system and/or by
direct infection of the B-cell lineage . Since viral load in
peripheral blood is low, these data suggest that B cells
in tissues such as spleen and lymph nodes could be an
in vivo reservoir for XMRV.
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